Class information for:
Level 1: RUNX3//AML1 ETO//AML1

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4826 1647 42.4 91%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
81 26583 MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RUNX3 Author keyword 115 60% 8% 127
2 AML1 ETO Author keyword 76 66% 4% 71
3 AML1 Author keyword 58 56% 4% 70
4 RUNX1 Author keyword 54 42% 6% 101
5 RUNX Author keyword 41 54% 3% 53
6 T8 21 Author keyword 29 88% 1% 14
7 CBF BETA MYH11 Author keyword 25 77% 1% 17
8 T821 Author keyword 20 41% 2% 37
9 CBF BETA SMMHC Author keyword 18 89% 0% 8
10 PEBP2 Author keyword 17 72% 1% 13

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 RUNX3 115 60% 8% 127 Search RUNX3 Search RUNX3
2 AML1 ETO 76 66% 4% 71 Search AML1+ETO Search AML1+ETO
3 AML1 58 56% 4% 70 Search AML1 Search AML1
4 RUNX1 54 42% 6% 101 Search RUNX1 Search RUNX1
5 RUNX 41 54% 3% 53 Search RUNX Search RUNX
6 T8 21 29 88% 1% 14 Search T8+21 Search T8+21
7 CBF BETA MYH11 25 77% 1% 17 Search CBF+BETA+MYH11 Search CBF+BETA+MYH11
8 T821 20 41% 2% 37 Search T821 Search T821
9 CBF BETA SMMHC 18 89% 0% 8 Search CBF+BETA+SMMHC Search CBF+BETA+SMMHC
10 PEBP2 17 72% 1% 13 Search PEBP2 Search PEBP2

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AML1 GENE 111 60% 7% 121
2 T8 21 105 58% 7% 122
3 AML1 97 50% 9% 142
4 CORE BINDING FACTOR 94 53% 8% 126
5 MULTIPLE CHROMOSOMAL TRANSLOCATIONS 87 74% 4% 64
6 FETAL LIVER HEMATOPOIESIS 84 49% 7% 123
7 FUSION TRANSCRIPT 71 44% 7% 122
8 RUNT DOMAIN 70 57% 5% 84
9 T8 21 FUSION PROTEIN 63 78% 3% 42
10 AML1 ETO FUSION TRANSCRIPT 58 86% 2% 30

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The RUNX family: developmental regulators in cancer 2015 4 190 52%
RUNX family: Regulation and diversification of roles through interacting proteins 2013 30 157 51%
RUNX3 is multifunctional in carcinogenesis of multiple solid tumors 2010 51 98 53%
The RUNX genes: Gain or loss of function in cancer 2005 241 179 53%
A role for RUNX1 in hematopoiesis and myeloid leukemia 2013 14 74 78%
The RUNX family in breast cancer: relationships with estrogen signaling 2013 30 183 38%
The 8; 21 translocation in leukemogenesis 2004 159 110 79%
Core Binding Factor at the Crossroads: Determining the Fate of the HSC 2010 21 80 80%
RUNX genes in development and cancer: Regulation of viral gene expression and the discovery of RUNX family genes 2008 90 122 44%
Oncogenic potential of the RUNX gene family: 'Overview' 2004 183 117 60%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ONCOGENESIS DEV SECT 6 42% 0.7% 11
2 HEMATOL MALIGNANCY TREATMENT 2 67% 0.1% 2
3 UVA HLTH SCI 2 67% 0.1% 2
4 CELL REGULATSAKYO KU 2 50% 0.2% 3
5 MOL ASPECTS HEMATOPOIESIS 2 24% 0.4% 6
6 BIOCHEM MOL BIOL F7 26 1 100% 0.1% 2
7 ORAL SCI DENTYONSEI BIOTECHNOL 1 100% 0.1% 2
8 QUEBEC LEUKEMIA CELL BANK 1 50% 0.1% 2
9 SURG PHYSIOL DIGEST SYSTKAMIGYO KU 1 100% 0.1% 2
10 SD 401 434 1 33% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000176444 CLEIDOCRANIAL DYSPLASIA//RUNX2//OSTERIX
2 0.0000150561 EVI1//EVI 1//3Q21Q26 SYNDROME
3 0.0000105140 TETRASOMY 8//NEAR TETRAPLOIDY//TRISOMY 4
4 0.0000100328 TEL AML1//LEUKAEMIA CYTOGENET GRP//ETV6
5 0.0000093133 NUP98//T711P15P15//DDX10
6 0.0000081976 PU1//SPI 1 PU1//SFPI1 PU1
7 0.0000073909 MLL//MLL GENE//11Q23
8 0.0000071277 ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML
9 0.0000067086 FLT3//FLT3 ITD//NPM1
10 0.0000054201 HEMANGIOBLAST//HEMOGENIC ENDOTHELIUM//AORTA GONAD MESONEPHROS